160 related articles for article (PubMed ID: 17727439)
1. Bravo capsule for wireless 48-h pH monitoring: proposed algorithm for its placement.
Marchese M; Spada C; Costamagna G
Am J Gastroenterol; 2007 Sep; 102(9):2104-5; author reply 2106. PubMed ID: 17727439
[No Abstract] [Full Text] [Related]
2. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
[TBL] [Abstract][Full Text] [Related]
3. Oesophageal pH monitoring using the Bravo catheter-free radio capsule.
Gillies RS; Stratford JM; Booth MI; Dehn TC
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):57-63. PubMed ID: 17206078
[TBL] [Abstract][Full Text] [Related]
4. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor.
Lacy BE; O'Shana T; Hynes M; Kelley ML; Weiss JE; Paquette L; Rothstein RI
Am J Gastroenterol; 2007 Jan; 102(1):24-32. PubMed ID: 17100980
[TBL] [Abstract][Full Text] [Related]
5. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
[TBL] [Abstract][Full Text] [Related]
6. Wireless capsules for esophageal pH monitoring: are we placing them correctly?
Doma S; Paladugu S; Parkman HP; Friedenberg FK
Digestion; 2010; 82(1):54-9. PubMed ID: 20215751
[TBL] [Abstract][Full Text] [Related]
7. Patients with functional heartburn are more likely to report retrosternal discomfort during wireless pH monitoring.
Lee YC; Wang HP; Chiu HM; Huang SP; Tu CH; Wu MS; Lin JT
Gastrointest Endosc; 2005 Dec; 62(6):834-41. PubMed ID: 16301022
[TBL] [Abstract][Full Text] [Related]
8. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure.
Marchese M; Spada C; Iacopini F; Familiari P; Shah SG; Tringali A; Costamagna G
Endoscopy; 2006 Aug; 38(8):813-8. PubMed ID: 17001571
[TBL] [Abstract][Full Text] [Related]
9. Previous wireless pH monitoring study overlooked.
Hochman J
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):607; author reply 607. PubMed ID: 18493221
[No Abstract] [Full Text] [Related]
10. Tolerability and clinical utility of the Bravo pH capsule in children.
Lacy BE; Edwards S; Paquette L; Weiss J; Kelley ML; Ornvold K
J Clin Gastroenterol; 2009 Jul; 43(6):514-9. PubMed ID: 19349903
[TBL] [Abstract][Full Text] [Related]
11. The Bravo pH capsule system.
Kwiatek MA; Pandolfino JE
Dig Liver Dis; 2008 Mar; 40(3):156-60. PubMed ID: 18096447
[TBL] [Abstract][Full Text] [Related]
12. Comparison of wireless 48-h (Bravo) versus traditional ambulatory 24-h esophageal pH monitoring.
Håkanson BS; Berggren P; Granqvist S; Ljungqvist O; Thorell A
Scand J Gastroenterol; 2009; 44(3):276-83. PubMed ID: 19040176
[TBL] [Abstract][Full Text] [Related]
13. Use and utility of the Bravo pH capsule.
Pandolfino JE; Kwiatek MA
J Clin Gastroenterol; 2008; 42(5):571-8. PubMed ID: 18364590
[TBL] [Abstract][Full Text] [Related]
14. Wireless capsule pH monitoring: does it fulfil all expectations?
Maerten P; Ortner M; Michetti P; Dorta G
Digestion; 2007; 76(3-4):235-40. PubMed ID: 18174686
[TBL] [Abstract][Full Text] [Related]
15. Review article: oesophageal pH monitoring--technologies, interpretation and correlation with clinical outcomes.
Kahrilas PJ; Pandolfino JE
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():2-9. PubMed ID: 16303031
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy, diagnostic utility and tolerance of intraesophageal pH ambulatory determination with wireless pH-testing monitoring system].
Carmona-Sánchez R; Solana-Sentíes S
Rev Gastroenterol Mex; 2004; 69(2):69-75. PubMed ID: 15757154
[TBL] [Abstract][Full Text] [Related]
17. Wireless upper esophageal monitoring for laryngopharyngeal reflux (LPR).
Friedman M; Schalch P; Vidyasagar R; Kakodkar KA; Mazloom N; Joseph NJ
Otolaryngol Head Neck Surg; 2007 Sep; 137(3):471-6. PubMed ID: 17765778
[TBL] [Abstract][Full Text] [Related]
18. Optimal thresholds and discriminatory power of 48-h wireless esophageal pH monitoring in the diagnosisof GERD.
Wenner J; Johansson J; Johnsson F; Oberg S
Am J Gastroenterol; 2007 Sep; 102(9):1862-9. PubMed ID: 17509034
[TBL] [Abstract][Full Text] [Related]
19. Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years.
Croffie JM; Fitzgerald JF; Molleston JP; Gupta SK; Corkins MR; Pfefferkorn MD; Lim JR; Steiner SJ; Dadzie SK
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):559-63. PubMed ID: 18030233
[TBL] [Abstract][Full Text] [Related]
20. Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes.
Domingues GR; Moraes-Filho JP; Domingues AG
Arq Gastroenterol; 2011; 48(1):24-9. PubMed ID: 21537538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]